Abstract
SUMMARYThree studies explored the effects of different diagnostic labels and different types of recommended treatments for Chronic Fatigue Syndrome upon attributions regarding its cause, nature, severity, contagion, prognosis, and treatment. Attributions for Chronic Fatigue Syndrome appear to change based upon the diagnostic label given for the syndrome and the type of treatment recommended. Results suggest that, in comparison to the Chronic Fatigue Syndrome label, the Myalgic Enceph-alopathy label prompts attributions that this syndrome is a serious condition associated with a physiologically-based etiology, a poor prognosis, and decreased potential for organ donation. Results also suggest that, compared with cognitive coping skills treatment, treatment with ampligen appears to be associated with perceptions of Chronic Fatigue Syndrome as an accurate diagnosis and as a severely disabling condition.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
